WALSH COLIN — SEC insider filings
SEC reporting owner CIK 1866174. 5 insider filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2021-06-28 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 1,170,000 shares, $20,570,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 46 legs across 2 filings — 211,614 shares, $4,503,315 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 500,000 shares @ $17.00 ($8,500,000) in Attovia Therapeutics, Inc., filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | Director | 2 | 4 legs · 1,170,000 sh · $20,570,000 | 46 legs · 211,614 sh · $4,503,315 | 14 |
| Elevation Oncology, Inc. (ELEV) | Director | 3 | — | — | 3 |
Insider filings — WALSH COLIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4/A | Attovia Therapeutics, Inc. (ATTO) | Purchase (P): 85,000 @ $21 · Sale (S): 988 @ $22.03 · Sale (S): 447 @ $21.87 · Sale (S): 1,332 @ $22.03 · Sale (S): 200 @ $22.05 · Sale (S): 1,556 @ $22.06 · +29 more | EDGAR |
| 2026-08-13 | 4 | Attovia Therapeutics, Inc. (ATTO) | Purchase (P): 85,000 @ $21 · Sale (S): 988 @ $22.03 · Sale (S): 447 @ $21.87 · Sale (S): 1,332 @ $22.03 · Sale (S): 200 @ $22.05 · Sale (S): 1,556 @ $22.06 · +23 more | EDGAR |
| 2023-06-21 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 31,238 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 15,619 (derivative) @ $0 | EDGAR |
| 2021-06-28 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 31,238 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1866174 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs